ICPF - Institut du Cancer de Polynésie française

What ICPF - Institut du Cancer de Polynésie française does

ICPF - Institut du Cancer de Polynésie française is a public health institution (établissement public de santé) founded in 2021 and headquartered in Pirae, French Polynesia. It serves as the designated regional cancer institute for the entire French Polynesian territory, coordinating cancer screening, epidemiological surveillance, and patient navigation across the major islands. The institute is structured around five operational divisions: Coordination, Registry, Screening, Communication, and Research, and employs 17 staff.

Its core service portfolio includes population-based cancer screening programs for breast, cervical, colorectal, prostate, and skin cancers; a population-based cancer registry (covering 2015-2019 data); an anatomopathology laboratory inaugurated in February 2026; EVASAN medical evacuation services; multidisciplinary RCP meetings; and the Docuthèque cancer resource library. Cancer incidence is meaningful at the territory scale, with reported volumes of 128 prostate cancer cases and 15 cervical cancer cases annually. The institute supplements its diagnostic and screening operations with the ARATA'I ONCO device and the Juin Vert (Green June) public awareness campaign.

The business model is that of a government-funded public health establishment with no commercial revenue. Screening services are free to patients and financed through the public health system; the institute is funded via governmental budget allocations specific to French Polynesia. There is no disclosed pricing model, customer acquisition motion, or commercial go-to-market. In April 2026, ICPF entered a partnership with Unicancer to operationalize clinical research through a URC (Unité de Recherche Clinique), aligning the institute with French national oncology research networks without altering its public-establishment status.

Name

ICPF - Institut du Cancer de Polynésie française

Legal name

Institut du Cancer de Polynésie Française

Website

https://icpf.pf

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

ICPF is the designated public cancer institute for French Polynesia, coordinating cancer screening, registry, pathology, and research across the territory's islands under a government-funded public health model.

Ownership category

akta.pro rank

Headquarters

HQ city

Pirae, Tahiti

HQ country

French Polynesia

HQ region

Oceania

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Distribution channels3 records

Marketing channels4 records

Core offering

ICPF is the regional cancer institute of French Polynesia providing organized cancer prevention, screening (breast, cervical, colorectal, prostate, skin), diagnosis (anatomopathology), research, and care coordination services across the territory. It maintains a cancer registry, hosts multidisciplinary team meetings (RCP), supports patient orientation through the ARATA'I ONCO device, and facilitates medical evacuations (EVASAN) for offshore patients.

Product overview

ICPF - Institut du Cancer de Polynésie française is a regional cancer institute providing a unified public health service for cancer prevention, screening, diagnosis, and research in French Polynesia. The organization operates through five interconnected divisions (Coordination, Registry, Screening, Communication, and Research) offering organized screening programs for breast, cervical, colorectal, prostate, and skin cancers, a recently inaugurated anatomopathology laboratory, a professional document library (Docuthèque), and medical evacuation services. The institute functions as a coordination hub connecting patients, healthcare professionals, and international cancer care networks including partnerships with Unicancer and French metropolitan cancer centers.

Differentiator

Problem solved

Functional benefit

Products and services

• Breast Cancer Screening Organized breast cancer screening program for women in French Polynesia, free of charge under the RGS regime. Designed for early detection and improved treatment outcomes.
• Cervical Cancer Screening Organized cervical cancer screening program for women in French Polynesia, accessible through the public health system. Aimed at early detection of cervical abnormalities.
• Colorectal Cancer Screening Organized colorectal cancer screening program covering the eligible adult population in French Polynesia, provided free of charge under public health insurance coverage.
• Prostate Cancer Screening Prostate cancer screening program for men in French Polynesia, available through the public health system.
• Skin Cancer Screening Organized skin cancer screening program for residents of French Polynesia, supporting early detection of dermatological malignancies.
• Anatomopathology Laboratory On-site anatomopathology laboratory providing local tissue and cell diagnostic analysis for cancer cases. Eliminates the need to send samples overseas and supports faster diagnosis for Polynesian patients.
• Docuthèque (Professional Document Library) Online repository of professional clinical documents, protocols, and reference materials for healthcare professionals working across French Polynesia.
• Dispositif ARATA'I ONCO Patient orientation device that coordinates oncology care pathways for patients and healthcare professionals across the territory.
• Cancer Registry (Registre des Cancers) Territorial cancer registry that collects and analyzes epidemiological data on cancer incidence and prevalence across French Polynesia, supporting public health planning and research.
• EVASAN (Medical Evacuation Program) Medical evacuation service that transports cancer patients from outer islands to Tahiti for treatment, supporting equitable access to specialty care across the territory.
• Multidisciplinary Team Meetings (RCP) Regular multidisciplinary team meetings (Réunions de Concertation Pluridisciplinaire) where clinicians collectively review cancer cases and determine treatment plans. Available to healthcare professionals across the territory.

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• UnicancercoreStrategic or Co-development Partner · 23 April 2026Unicancer, the French national network of cancer centers, partnered with ICPF in April 2026 on a new mission to develop clinical research in French Polynesia. This partnership aims to strengthen research capabilities and integrate ICPF into the broader French cancer research ecosystem.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Cancer Council Australia: Australian national non-profit coordinating cancer prevention, screening, research funding, and patient support. Comparable mission and structure to ICPF, but operating in a different geography.

Direct peers

• Institut Curie: Paris-based cancer research and treatment center combining a hospital, research center, and registry functions. Comparable to ICPF in offering integrated cancer care, research, and epidemiologic surveillance.
• Institut National du Cancer (INCa): France's national cancer institute coordinating cancer policy, screening, registry, and research. Directly comparable to ICPF as a national/territorial-level public cancer authority with an analogous mission.
• Unicancer: French national network of cancer centers coordinating clinical research and cancer care. Directly comparable as the network partner ICPF has signed with and the broader ecosystem ICPF is integrating into.
• Centre Léon Bérard: Unicancer-member comprehensive cancer center in Lyon focused on treatment, research, and screening coordination. Comparable as a Unicancer-network cancer center offering the integrated care model ICPF aspires to.

Others

• Santé Publique France: France's national public health agency running national screening programs and population surveillance. Comparable as the parent public-health ecosystem that funds and coordinates cancer screening activities.
• International Agency for Research on Cancer (IARC/WHO): WHO agency specializing in cancer epidemiology, registry methodology, and global cancer research. Comparable to ICPF's registry and research functions, particularly for population-based cancer surveillance.

Broad incumbents

• Gustave Roussy: Largest cancer center in Europe, providing comprehensive treatment, research, and screening programs. Comparable as a broad incumbent offering the full oncology stack that ICPF coordinates at a regional level.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ICPFPolynesie
• Facebookfacebook.com/icpf.polynesie
• LinkedInlinkedin.com/company/icpfpolynesie
• Instagraminstagram.com/icpf.polynesie

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICPF - Institut du Cancer de Polynésie française